Clinical Trial Update: A Single-Center Clinical Study on the Efficacy and Safety of VISOR [NA]

View source ↗

Summary

A single-center clinical study is evaluating the efficacy and safety of VISOR for urolithiasis due to calcium oxalate (kidney stones) and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urolithiasis

Drugs mentioned

• VISOR

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Urolithiasis, Calcium Oxalate, Kidney Stone | NA | Status: RECRUITING